D. Jackson et al., IMPACT OF L-DOPA ON STRIATAL ACETYLCHOLINE-RELEASE - EFFECTS OF 6-HYDROXYDOPAMINE, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 912-918
We investigated the effects of the dopamine (DA) precursor L-dihydroxy
phenylalanine (L-DOPA) on electrically evoked acetylcholine (ACh) over
flow from rat striatal slices. Some animals were pretreated 1 to 2 mon
ths earlier with 6-hydroxydopamine, (6-OHDA), a catecholamine neurotox
in, so as to selectively destroy DA terminals (98.6% striatal DA deple
tion). Although the addition of L-DOPA (10 muM) produced a 37% inhibit
ion of ACh overflow in slices from lesioned rats, it failed to affect
ACh overflow in slices from intact animals. In contrast, ACh overflow
from intact slices exposed to L-DOPA and to the DA uptake inhibitor no
mifensine (1 muM) was 22% greater than in the presence of nomifensine
without L-DOPA. ACh overflow from slices prepared from lesioned rats w
as 45% greater with both drugs than in the presence of nomifensine by
itself. Superfusion with the aromatic L-amino acid decarboxylase (AADC
) inhibitor NSD-1055 (250 muM) abolished the inhibitory effects of L-D
OPA, as did L-sulpiride (1 muM), an inhibitor of DA receptors of the D
2 subtype. These results suggest that inhibition of ACh overflow by L-
DOPA is mediated by DA formed from exogenous L-DOPA which then acts on
D2 receptors. They further indicate that the net impact of the loss o
f nigrostriatal terminals is an increased dopaminergic inhibition of s
triatal cholinergic interneurons in response to exogenous L-DOPA. This
appears to result in large part from a lesion-induced reduction in hi
gh-affinity reuptake of DA formed from exogenous L-DOPA.